Release Date: 25/10/11 08:47 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 4.41MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%